United States
Germany
Japan
United Kingdom
China
CNY 800.00
现货
SERPINA1 mouse monoclonal antibody, clone OTI5B12 (formerly 5B12)
| Applications | IHC, IP, WB |
| Reactivities | Human, Dog, Monkey |
Antibodies
Anti-NRBP1 (MADM) mouse monoclonal antibody, clone OTI7C5 (formerly 7C5)
| Applications | FC, IHC, IP, WB |
| Reactivities | Human, Monkey, Mouse, Rat, Dog |
Anti-PLK1 mouse monoclonal antibody, clone OTI8C12 (formerly 8C12)
| Applications | FC, IF, IP, WB |
| Reactivities | Human, Dog, Monkey, Mouse, Rat |
CNY 800.00
现货
SERPINA1 mouse monoclonal antibody, clone OTI15H10 (formerly 15H10)
| Applications | IHC, IP, WB |
| Reactivities | Human, Dog, Monkey |
Anti-NRBP1 (MADM) mouse monoclonal antibody, clone OTI7E2 (formerly 7E2)
| Applications | FC, IHC, IP, WB |
| Reactivities | Human, Dog, Rat, Monkey, Mouse |
Anti-MAPK1 (ERK2) mouse monoclonal antibody, clone OTI7E7 (formerly 7E7)
| Applications | IF, IP, WB |
| Reactivities | Human, Dog, Rat, Monkey, Mouse |
Anti-MAPK1 (ERK2) mouse monoclonal antibody, clone OTI7C9 (formerly 7C9)
| Applications | IF, IP, WB |
| Reactivities | Human, Dog, Rat, Monkey, Mouse |
Anti-BRAF mouse monoclonal antibody, clone OTI3A7 (formerly 3A7)
| Applications | IF, IP, WB |
| Reactivities | Human, Dog, Rat, Monkey, Mouse |
NEUROG1 (Neurogenin 1) mouse monoclonal antibody, clone OTI8G8 (formerly 8G8)
| Applications | IF, IP, WB |
| Reactivities | Human, Dog, Mouse, Rat |
Anti-MAPK1 (ERK2) mouse monoclonal antibody, clone OTI4D10 (formerly 4D10)
| Applications | IP, WB |
| Reactivities | Human, Dog, Rat, Monkey, Mouse |
Anti-MAPK1 (ERK2) mouse monoclonal antibody, clone OTI1D3 (formerly 1D3)
| Applications | IP, WB |
| Reactivities | Human, Dog, Rat, Monkey, Mouse |
Anti-BRAF mouse monoclonal antibody, clone OTI3B12 (formerly 3B12)
| Applications | IP, WB |
| Reactivities | Human, Dog, Monkey, Mouse, Rat |
活动过滤器
clear Category
-
Antibodies
- Primary Antibodies
优化搜索结果
Target Symbol
Knockout (KO) Validation
Isotypes
Clonalities
Assay Types
Brands
Pathways
- Progesterone-mediated oocyte maturation (39)
- Bladder cancer (36)
- ErbB signaling pathway (36)
- MAPK signaling pathway (36)
- Pathways in cancer (36)
- Acute myeloid leukemia (33)
- Chemokine signaling pathway (33)
- Chronic myeloid leukemia (33)
- Colorectal cancer (33)
- Endometrial cancer (33)
- Focal adhesion (33)
- Glioma (33)
- Insulin signaling pathway (33)
- Long-term depression (33)
- Long-term potentiation (33)
- Melanoma (33)
- Natural killer cell mediated cytotoxicity (33)
- Neurotrophin signaling pathway (33)
- Non-small cell lung cancer (33)
- Pancreatic cancer (33)
- Prostate cancer (33)
- Regulation of actin cytoskeleton (33)
- Renal cell carcinoma (33)
- Thyroid cancer (33)
- Vascular smooth muscle contraction (33)
- mTOR signaling pathway (33)
- Oocyte meiosis (30)
- Fc epsilon RI signaling pathway (27)
- Gap junction (27)
- GnRH signaling pathway (27)
- Toll-like receptor signaling pathway (27)
- Adherens junction (24)
- Alzheimer's disease (24)
- Axon guidance (24)
- B cell receptor signaling pathway (24)
- Dorso-ventral axis formation (24)
- Fc gamma R-mediated phagocytosis (24)
- Melanogenesis (24)
- NOD-like receptor signaling pathway (24)
- Prion diseases (24)
- T cell receptor signaling pathway (24)
- TGF-beta signaling pathway (24)
- Type II diabetes mellitus (24)
- VEGF signaling pathway (24)
- Cell cycle (21)
- p53 signaling pathway (15)
- Complement and coagulation cascades (12)
- Metabolic pathways (9)
- Arachidonic acid metabolism (6)
- DNA replication (6)
- Homologous recombination (6)
- Mismatch repair (6)
- Nucleotide excision repair (6)
- Alanine (3)
- Butanoate metabolism (3)
- Epithelial cell signaling in Helicobacter pylori infection (3)
- Pathogenic Escherichia coli infection (3)
- Taurine and hypotaurine metabolism (3)
- Type I diabetes mellitus (3)
- aspartate and glutamate metabolism (3)
- beta-Alanine metabolism (3)
